SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-047820
Filing Date
2021-09-13
Accepted
2021-09-13 20:36:59
Documents
2
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 3  
1 OWNERSHIP DOCUMENT ownership.xml 3 1629
2 POWER OF ATTORNEY ea147338ex24_clarustherap.htm EX-24 10106
  Complete submission text file 0001213900-21-047820.txt   13232
Mailing Address 1414 RALEIGH ROAD SUITE 400 CHAPEL HILL NC 27517
Business Address
Cermak Elizabeth (Reporting) CIK: 0001471971 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39802 | Film No.: 211251006

Mailing Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062
Business Address 555 SKOKIE BOULEVARD, SUITE 340 NORTHBROOK IL 60062 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Issuer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)